FDA D.I.S.C.O. Burst Edition: FDA approval of Orencia (abatacept) for prophylaxis of acute graft versus host disease
0:00
5:29
Listen to a soundcast of the December 15, 2021 FDA approval of Orencia (abatacept) for prophylaxis of acute graft versus host disease.
Altri episodi di "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Non perdere nemmeno un episodio di “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)”. Iscriviti all'app gratuita GetPodcast.